Presented at: National Meeting of the American Chemical Society San Diego, CA April 3, 2001 Presented by: Anthony Breitzman, VP/CTO Patrick Thomas, Research.

Slides:



Advertisements
Similar presentations
Water Market USA Published by Global Water Intelligence.
Advertisements

Business Plans Simonyi Center.
© 2006 Morrison & Foerster LLP All Rights Reserved AN OVERVIEW OF CROSS BORDER MERGERS AND ACQUISITIONS Bruce Mann October 17, 2006.
Chapter 20 CONTROLLING FOR ORGANIZATIONAL PERFORMANCE
CFO Presentation Background This is a presentation to a banker who the company wants a loan from and is a targeted financial statement analysis. This is.
CIPLA LTD Analyst Report By Siddharth Ghaisas. WHO IS CIPLA & WHAT DO THEY DO? WHO WHO - The Chemical, Industrial & Pharmaceutical Laboratories; - Founded.
Student Version.
“BUYERS AND SELLERS” What they really really want......
Industry and Competitive Analysis
STRATEGIC MANAGEMENT & BUSINESS POLICY 12TH EDITION
COST Action IS0905 Emergence of Southern Multinationals and their Impact on Europe COST İstanbul Meeting May 24-25, 2011 This research is funded by the.
Bioinformatics: Players, Problems, and Processes in Computational Biology This is a comprehensive report about the growing technology sector of bioinformatics.
Chapter 13 Common Stock Valuation Name two approaches to the valuation of common stocks used in fundamental security analysis. Explain the present value.
COLLABORATION STRATEGIES
1 Pertemuan Kesepuluh Industry and Competition Analysis.
VALUATION OF FIRMS IN MERGERS AND ACQUISITIONS OKAN BAYRAK.
Copyright © 2011 Pearson Education, Inc. Publishing as Prentice Hall Ch 3 -1 Chapter 3 The External Assessment Strategic Management: Concepts & Cases 13.
Investing in Financials August 2011 Christian Koch, CFP ® (404) KAMSouth.com.
M&A STRATEGY One of most fundamental motives for M&A is growth. Companies seeking to expand are faced with a choice between internal or organic growth.
THE BUSINESS RESEARCH COMPANY HEALTHCARE CASE STUDIES.
TAKEOVERS, MERGERS AND BUYOUTS
Giving Your Business ESP SM Chris Andersen President 425 Market St., #2200 San Francisco, CA
Copyright ©2004 Pearson Education, Inc. All rights reserved. Chapter 18 Asset Allocation.
Chapter 20 CONTROLLING FOR ORGANIZATIONAL PERFORMANCE © 2003 Pearson Education Canada Inc.20.1.
UNDERSTANDING BUYERS + MARKETS Principles of Marketing Week 4.
1 Indicators of Knowledge Value Conference on Estimating the Benefits of Government Sponsored Energy R&D Department of Energy At Hilton Crystal City -
PowerPoint Slides for Instructors
Efficient Capital Markets Objectives: What is meant by the concept that capital markets are efficient? Why should capital markets be efficient? What are.
Future of Aerospace industry Role of M&A in it’s forthcoming growth Global Trends Rzeszów, 26 June 2012 Adam Czechanowski Senior Manager, Audit Jakub Podleśny.
Return, Risk, and the Security Market Line
Real Options in Equity Partnerships Author: Timothy B. Folta & Kent D. Miller Source: Strategic Management Journal (2002), Vol. 23, pp Presented.
Revise Lecture Mergers and Acquisitions Three measure of corporate growth? Internal growth & External growth? Reasons firm’s seek to grow? 2.
Business Plans For The Real World. Why a Business Plan? Strategic Guide Lenders Investors.
Internet Data Base Information Retrieval Services.
Topics → Business strategy must set goals → Partners selection → Criteria for selecting partners → Structure must maximize cooperation → Incentives for.
Public Financial Services, LLC Investor Briefing Reaching Liquidity.
What Is Strategy? Distinguishing strategy from tactics: –Strategy is the overall plan for deploying resources to establish a favorable position. –Tactic.
Revise Lecture 29. Mergers and Acquisitions 1.Merger & Consolidation ? 2.Four ways of merger ? 3.Three types of merger? 4.Resisting in acquisition?
Mergers and takeover. Measure of corporate growth Increase in sales It indicates size or quantity in the market Increase in profit Operations into greater.
Joseph L. Petrelli, ACAS, MAAA, FCA Demotech, Inc. National Settlement Services and Compliance Summit Panelists: Joseph Piernock, Carl Grimes & Joseph.
STRATEGIC CAPABILITY By: Vedika Saraf Swagata Giri Yukti Agarwal Vikram Pesswani Vivek Sood Srishti Seth Sumalya.
Introduction to Management LECTURE 17: Introduction to Management MGT
0 11-May-2003 From Science Papers to Technology Patents to Company Financial Performance Presented by: Francis Narin, President CHI Research, Inc. 10 White.
From Ideas to Assets chapter 14 “Using Patent Indicators to Predict Stock Portfolio Performance” Summarized by Kibeum Ryoo.
Firms make acquisitions to create value for shareholders Reasons often cited for making acquisitions – improve the performance of the company – consolidate.
Francesco Crespi University of “Roma Tre” Mario Pianta University of Urbino ISAE - Monitoring Italy 2007, Rome 18th October 2007 New processes, old patterns.
1 Key Figures 2007 on Science Technology and Innovation From the pre-publication of DG RTD Key Figures 2007 Andrea Tilche Ad Hoc Group on Innovation in.
Lecture 18. Lecture Review Volume of world mergers and acquisition International Acquisitions Defensive tactics against Hostile takeover.
Chapter 20 External Growth through Mergers. McGraw-Hill/Irwin © 2005 The McGraw-Hill Companies, Inc., All Rights Reserved. PPT 20-1 TABLE 20-1 Largest.
Strategic alliances Joint venture Merger & acquisition.
Copyright © 2012 by The McGraw-Hill Companies, Inc. All rights reserved. Slides prepared by Hersh Shefrin Managing Growth Chapter Four.
The Global Military Aircraft Engines Market
Copyright © Pearson Education Limited 2015 The External Audit The External Audit Chapter Seven 7-1.
Mergers & Acquisitions- Management Design Associates’ Sell-Side Services THE FOUR PHASES OF THE MERGER & ACQUISITION PROCESS.
Case Studies /Valuation SMIF Meeting #2. Intuitive Surgical (ISRG)
© Copyright 2003 Frost & Sullivan. All Rights Reserved. Strategic Assessment of Oncology Research and Opportunities in the Asia Pacific Biotech Markets.
“Increase in Research Funding & Technological Advancements Drive the Global Microscopes Market” For more details, please visit-
Andy Passey September 23rd 2003 Advanced Wound Management in Europe: Market Overview and Critical Success Factors © 2003 Frost & Sullivan. All rights reserved.
Entrepreneurial Strategies. A Major Shift... From financial capital to intellectual capital – Human – Structural – Customer.
MERGERS & ACQUISITIONS FIN 335 Supplemental Material.
R&D Capabilities and International, Intra- National and Inter-firm Knowledge Diffusion in China: The Case of the Semiconductor Industry Rui Wang Seoul.
Chapter 20 CONTROLLING FOR ORGANIZATIONAL PERFORMANCE
JRC – Territorial Development Unit Petros Gkotsis 08 March 2017
Investments in Other Corporations
Technology Assessment and Acquisition in the US Electronics Manufacturing Industry Tugrul U Daim, Ph.D.
VALUATION OF FIRMS IN MERGERS AND ACQUISITIONS
Acquisition and Restructuring Strategies
DIVERSIFICATION STRATEGIES
BCM Group, LLC. Deliver custom market entry and business development services to non-US manufacturers of innovative products and technologies targeting.
Presentation transcript:

Presented at: National Meeting of the American Chemical Society San Diego, CA April 3, 2001 Presented by: Anthony Breitzman, VP/CTO Patrick Thomas, Research Analyst CHI Research, Inc. 10 White Horse Pike Haddon Heights, NJ Identifying Undervalued Companies Via Patent Analysis As a Means of Highlighting Merger/Acquisition Targets

2 Introduction Mergers and acquisitions take place for a variety of reasons, including strategic growth, expansion into new markets, or because the target company is attractively priced and contains know-how the suitor would like to obtain. In this presentation we will concentrate on the third issue; that is, the use of patent analysis in the valuation of companies.

3 Key Questions in Analyzing Mergers between Technology Based Companies 1.Does the merger make sense in technological terms? –Are the firms technologically compatible? –Does the merger fill a technological gap? 2.Are the financial terms of the merger appropriate? –Is the buying firm getting a fair price? –Is there a best target in terms of technology and price? Patent analysis can help frame both issues.

4 Overview Slide 5: Introduction to patent analysis Slides 6-9: Traditional uses of patent analysis in M&A Situations Slides 10-22: Use of patent analysis in valuing companies

5 Patent Analysis Basics  Patent and Patent Family counts can be used to measure the level of R&D activity.  Impact or value of R&D activity can be measured by weighting patent activity against patent indicators such as citation counts, number of equivalent documents, renewal decisions, science linkage, innovation speed, etc. For more on patent analysis see CHI Publication List: papers 146, 113, 103 among others.

6 Traditional Uses of Patent Analysis in M&A Situations  Targeting  Due Diligence  Technological Compatibility And now  Valuation

7 Recent Targeting Examples  A large pharmaceutical company wishes to identify small biotech firms with strong genomics capabilities.  A South American cosmetics company wishes to manufacture anti-perspirants in Europe. Which European firms have the technological capabilities and might be viable acquisition targets?  A large semiconductor firm wants to invest in firms doing bioinformatics. Who has the best and are they for sale?

8 Due-Diligence Examples  Is the firm everything it seems technologically? Are the key inventors still with the firm? We once did a due-diligence analysis where the key inventor was moved to the parent company, before the sale of a subsidiary.  We once killed an acquisition of a hearing-aid company. The target had a strong sales network, but its technology was all analog while the competition was going digital.

9 Technological Compatibility Examples  Is the acquisition active in the same areas as the acquiring company? Does the firm fill a technological niche or gap that the acquiring company needs filled?  Recently we showed that the Glaxo-SmithKline merger was a good technological fit because both companies are active in largely the same treatment areas, but Glaxo would gain entry into a number of new areas. Also their strengths are complimentary. SmithKline would strengthen Glaxo’s weaker pharmaceutical technology, while Glaxo’s strong biotechnology and basic chemistry research would strengthen SmithKline’s weaker standing in those areas.

10 Basic Idea of Valuation Methodology  O nce a target or targets are identified, what is a reasonable price for that target?  Patent analysis can be used in the following way: 1.All players in the technology can be identified via patent activity. 2.A market-to-book value can be identified for the publicly traded subset. 3.Regression analysis can be used to correlate market-to-book values with patent impact indicators. 4.A target price is set based on where the target fits among its peers in patent indicators. 5.If the company is public, and its target price is above its actual price, than it is undervalued, and is a good buy.

11 Valuation Example 1 – Who is the best Biotech Target?

12 Footnotes to Previous Slide 1.Technology Score is a linear combination of various patent indicators. These are then percentile ranked by industry so that companies with a percentile score of 100 have the strongest technology indicators within the industry. 2.Regression analysis is used to determine the MTB level for a company with a particular tech. score within an industry. Once an MTB is determined, a price-per-share can be easily determined. 3.By comparing a company's actual price with its tech-score price, one can determine whether a company is over or under-valued in the market.

13 Example 2: Glaxo Purchased SmithKline at a Bargain Price

14 Example 3: Acuson Case Study. In Ultrasound Technology Acuson is One of the Most Prolific Patenters, Its Patents are Highly Influential, and Have the Closest Links to Scientific Research

15 Example 3: Acuson Case Study. Acuson is at the Center of the Latest Developments in Ultrasound Technology (Linkage Map shows Citation Relationships Between Companies)

16 Example 3: Acuson Case Study. Acuson’s Patents are Influential both Inside and Outside the Ultrasound Industry Patent Title: Ultrasonic Harmonic Imaging System and Method

17 Example 3: Acuson Case Study. On August 15th, CHI selected Acuson for inclusion in Nike Securities’ Patent Quality Trust Siemens Purchased Acuson at a 50% Premium on September 27th

18 Example 3: Acuson Case Study. Key Facts  Patent analysis showed that Acuson’s ultrasound technology was very good relative to its peers.  Its stock price indicated it was undervalued relative to its industry and its technological quality.  The conclusion at the time (August 2000) was that Acuson was ripe for either a takeover or a substantial rise in stock price.

19 Can the Acuson Example be Generalized?  Yes. The method can and has been generalized to identify undervalued companies whose stocks should rise.  The method is the subject of a recently issued and another pending patent.  The basic idea of the method is that once a company’s industry is identified, one can always tell 1) whether its patents are as good or better than its peers and 2) whether this is reflected in its stock price.

20 Companies Undervalued Based on Patent Scores are More Likely to Experience Increased Market-to-Book (and hence increased stock prices).

21 $100 invested in the most undervalued companies (refreshed each year) would return over 2000% in 10 years.

22 But how does it perform in a bear market? The market has been unkind overall so far this year, but the undervalued companies have done well.

23 For More Information and Related Papers Visit: Or Contact: Tony Breitzman VP/CTO CHI Research, Inc. 10 White Horse Pike Haddon Heights, NJ Ph:  Fax: